PartnershipUpdated on 30 March 2026
Companion digital intervention for metabolic therapies (CGM + nutrition + coaching)
Cofounder & CSO at Clear.bio
Amsterdam, Netherlands
About
Clear.bio is a CE-marked digital intervention for people with Type 2 Diabetes that complements pharmacological treatments by translating real-time CGM data into personalised, actionable lifestyle guidance.
By combining glucose insights with tailored nutrition advice and remote dietitian coaching, Clear.bio supports improved treatment response, stronger patient engagement, and better adherence in daily practice. The intervention is already reimbursed and implemented in primary care in the Netherlands, with strong real-world outcomes.
We collaborate with pharma and medtech partners to develop companion programs around metabolic therapies such as GLP-1, SGLT2 inhibitors, and insulin, including joint pilots with providers and payers and the generation of real-world evidence.
We are looking for partners interested in integrated care solutions and improving outcomes through a combination of therapy and behaviour.
Similar opportunities
Project cooperation
Type 2 diabetes DTx pilot in Germany
Madelon Bracke
Cofounder & CSO at Clear.bio
Amsterdam, Netherlands
Partnership
Reimbursed digital diabetes intervention seeking insurer pilots in Europe
Madelon Bracke
Cofounder & CSO at Clear.bio
Amsterdam, Netherlands
Investment
Clear.bio (NL) is seeking investment for international expansion
Madelon Bracke
Cofounder & CSO at Clear.bio
Amsterdam, Netherlands